Skip to main content
See every side of every news story
Published loading...Updated

Muscle-Invasive Bladder Cancer: New Standard for Perioperative Systemic Therapy

Berlin – In cases of muscle-invasive bladder cancer, radical cystectomy with pelvic lymph node dissection is unavoidable, possibly in conjunction with cisplatin-based neoadjuvant chemotherapy. In high-risk cases, perioperative immunotherapy with durvalumab or adjuvant nivolumab treatment may also be considered...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

2 Articles

Berlin – In cases of muscle-invasive bladder cancer, radical cystectomy with pelvic lymph node dissection is unavoidable, possibly in conjunction with cisplatin-based neoadjuvant chemotherapy. In high-risk cases, perioperative immunotherapy with durvalumab or adjuvant nivolumab treatment may also be considered...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news in on Wednesday, November 5, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal